Introduction

Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors

Useful links

• Further event details More information about the event

Speakers

• Dr Jonathan Bright AstraZeneca, United Kingdom
• John Cleverley Clarivate Analytics, United Kingdom
• Dr Paul Fullerton AMRI, United Kingdom
• Conor Jamieson Sandwell and West Birmingham NHS Trust, United Kingdom
• Dr Nigel McSweeney FreeThink Technologies Inc, United Kingdom
• Dr Rachel Orr GSK, United Kingdom
• Dr Garry Scrivens Pfizer, United Kingdom
• Susan Smith AstraZeneca, United Kingdom

---

Venue

The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

• Venue information More information about the venue

Organised by

JPAG

Contact information

John Clements
JPAG
Contact us by email

---